NorthLinks Bio

Private

Boston, MassachusettsHealthcare & Life Scienceshttps://www.northlinksbio.com/

Last Round

Series A

Jun 23, 2026

Total Funding Raised

$34M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

NorthLinks Bio is a biotechnology company developing broad-spectrum antiviral preventative medicines for respiratory viral infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

broad-spectrum prophylacticantiviral nasal sprayhost-directed therapystrain-agnostic antiviralrespiratory virus prophylacticviral entry inhibitorglycan-targeted platformpandemic preparednesspre-exposure prophylaxisclinical-stage biotechintranasal sprayantiviral development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NorthLinks Bio Comps

Public and private peers based on sector, stage, and business model.

NorthLinks Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NorthLinks Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 23, 2026

View all Funding Rounds

NorthLinks Bio Investors

Notable investors and investment history

NorthLinks Bio investors
Investor	Rounds
RA Capital Management	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 23, 2026
$34M raised, led by RA Capital Management.

View all signals

NorthLinks Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NorthLinks Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NorthLinks Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts

Year Founded2026

Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.